ILF2 and cancer: ILF3/ILF2 acts as a trans-regulator of RNA editing by interacting with adenosine deaminase RNA specific proteins (DAR1 and ADAR2, providing a link to cancer and epithelial-to-mesenchymal transition [169,170]).